Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment.
Yang J, Savvatis K, Kang JS, Fan P, Zhong H, Schwartz K, Barry V, Mikels-Vigdal A, Karpinski S, Kornyeyev D, Adamkewicz J, Feng X, Zhou Q, Shang C, Kumar P, Phan D, Kasner M, López B, Diez J, Wright KC, Kovacs RL, Chen PS, Quertermous T, Smith V, Yao L, Tschöpe C, Chang CP.
Yang J, et al. Among authors: kornyeyev d.
Nat Commun. 2016 Dec 14;7:13710. doi: 10.1038/ncomms13710.
Nat Commun. 2016.
PMID: 27966531
Free PMC article.